Product Name	Paclitaxel
Assay	99%
Test Method	HPLC
Appearance	White Powder
CAS NO	33069-62-4
Molecular Formula	C47H51NO14

Paclitaxel powder is a chemotherapy drug that is given as a treatment for some types of cancer. Paclitaxe powder is a mitotic inhibitor now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxe is also used for the prevention of restenosis.

ITEM	SPECIFICATION	RESULTS
Appearance	Fine powder	Complies
Colorl	White	Complies
Odor&Taste	Characteristic	Complies
Assay	≥99%	99.53%
Heavy Metals	≤10ppm	Complies
Pb	≤2ppm	Complies
As	≤2ppm	Complies
Hg	≤1ppm	Complies
Cadmium	≤1ppm	Complies
Sulphates	≤300ppm	Complies
Ammonium	≤200ppm	Complies
Iron	≤10ppm	Complies
Microbiological Control
Total plate count	≤1000CFU/G	Complies
Yeast & mold	≤100 CFU /G	Complies
Total coli forms	≤100 CFU /G	Complies
E.coli	Negative	Negative
Salmonella	Negative	Negative

1. Paclitaxel is a mitotic inhibitor drup used in the treatment of cancer.

2. Isolated the compound from the bark of the Pacific yew tree, Taxus brevifolia, and noted its antitumor activity in a broad range of rodent tumors.

3. Paclitaxel has since become an effective tool of doctors who treat patients with lung, ovarian, breast cancer, and advanced forms of Kaposi's sarcoma.